Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer
Irene Yu, Anthony Dakwar, Kazuaki Takabe
Cells (2023) Vol. 12, Iss. 2, pp. 258-258
Open Access | Times Cited: 21

Showing 21 citing articles:

Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments
Roya Abedizadeh, Fatemeh Majidi, Hamid Reza Khorasani, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 2, pp. 729-753
Closed Access | Times Cited: 27
Magnetic Particle Imaging: From Tracer Design to Biomedical Applications in Vasculature Abnormality
Xulin Xie, Jiao Zhai, Xiaoyu Zhou, et al.
Advanced Materials (2023) Vol. 36, Iss. 17
Open Access | Times Cited: 14
Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons
Jan Clerick, Aude Van Oosterwyck, Saskia Carton
Cancer Treatment and Research Communications (2024) Vol. 39, pp. 100807-100807
Open Access | Times Cited: 4
Diagnostic Advances and Novel Therapeutics in Peritoneal Metastasis
Gregory Sigler, Jacqueline A. Murtha, Patrick R. Varley
Surgical Oncology Clinics of North America (2025)
Closed Access
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Liver Transplantation for Non-Hepatocellular Carcinoma: Role of Immune Checkpoint Inhibitors
Pegah Bahrami, Mohammad Al Zein, Ali H. Eid, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102558-102558
Closed Access
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II–III colorectal cancer
Haijiao Zhang, Rangrang Wang, Tianyu Yu, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 164-178
Open Access | Times Cited: 3
Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer
Abdo Jurjus, Jad El Masri, Maya Ghazi, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1236-1236
Open Access | Times Cited: 3
Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis‐related genes in colorectal cancer
Xiang Zhai, Baoxiang Chen, Heng Hu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 3
Advancements in immunotherapy for colorectal cancer treatment: a comprehensive review of strategies, challenges, and future prospective
Vaishak Kaviyarasan, Alakesh Das, Dikshita Deka, et al.
International Journal of Colorectal Disease (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Update on Mucoadhesive Approaches to target Drug Delivery in Colorectal Cancer
Neha Kanojia, Komal Thapa, Nitin Verma, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104831-104831
Closed Access | Times Cited: 6
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
Xing He, Huanrong Lan, Ketao Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Chunhua Wu, Wenfei Li, Mifen Chen, et al.
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer
Mengmeng Lv, Sheng Guo, Xinyu Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110918-110918
Closed Access | Times Cited: 3
Hsa_circRNA_001676 accelerates the proliferation, migration and stemness in colorectal cancer through regulating miR-556-3p/G3BP2 axis
Qin Hao, Miao Zhang, Yingcai Wu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions
Jiao-Ting Chen, Yuwen Zhou, Ting-Rui Han, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
The Potential Role of Intestinal Stem Cells and Microbiota for the Treatment of Colorectal Cancer
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, et al.
Advances in experimental medicine and biology (2024), pp. 115-128
Closed Access
Genomics – The barriers are falling
Sue Clark
Colorectal Disease (2024) Vol. 26, Iss. 7, pp. 1330-1331
Closed Access
Pyroptosis: A promising biomarker for predicting colorectal cancer prognosis and enhancing immunotherapy efficacy
Jiayi Wang, Y. Lu, Fang Li, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 8, pp. 968-974
Open Access
Advancements in immunotherapy research for colorectal cancer based on microsatellite status
Shuai XIAO, XiGuang CHEN, XuYu ZU
Scientia Sinica Vitae (2023) Vol. 53, Iss. 10, pp. 1455-1466
Closed Access
Page 1

Scroll to top